This protocol outlines the methodology for utilizing a lip fixation device in labial salivary gland biopsy, along with its associated advantages.
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
This protocol outlines the methodology for utilizing a lip fixation device in labial salivary gland biopsy, along with its associated advantages.
The protocol aims to standardize and simplify labial salivary gland biopsy (LSGB) in suspected Sjögren's disease (SjD) using a lip fixation device, enabling safe, efficient, and operator-independent procedures with reduced technical difficulty, especially for junior rheumatologists. We developed a step-by-step protocol encompassing preoperative assessment, antisepsis, local anesthesia, device-assisted lip stabilization, precise vertical incision (5-7 mm), blunt dissection, gland harvesting (minimum 4-6 glands), and standardized closure. The device consists of two clamp arms, an oval pressure ring (major axis 2.4 cm, minor axis 1.5 cm), a matching backing plate separated by a 2.1 cm gap, and a precision screw mechanism. After the patient was positioned supine on the bed, clinical inspection was performed, followed by a "go/no-go" assessment to exclude localized active infection, mucosal ulceration, significant debris, or lip masses. Triple antisepsis is performed with alcohol-free Type III povidone-iodine. Local infiltration anesthesia is administered away from the incision site. The lip is everted and stabilized by the device; a vertical incision is made parallel to the pressure ring axis, penetrating the epithelium while avoiding deep glands or muscle. Glands are identified as pale-yellow translucent spherules (1-2 mm) and harvested by blunt dissection. Closure is achieved with a single interrupted suture, and hemostasis is verified. The protocol enables solo performance, reduces procedure time compared with conventional methods (8.72 ± 1.88 min vs. 18.11 ± 2.65 min, p < 0.001), yields comparable complication rates between groups (all p > 0.05), and ensures acquisition of adequate tissue (>8 mm², focus score assessment feasible). The device's elastic compression prevents tissue injury despite secure stabilization, and predefined troubleshooting steps manage bleeding or suboptimal yield. This protocol standardizes LSGB with a fixation device, overcoming manual retraction challenges, reducing reliance on assistants, and supporting training and quality assurance in rheumatology, while maintaining diagnostic accuracy and patient safety.
Sjögren's disease (SjD) is a chronic autoimmune disorder characterized by lymphocytic infiltration of exocrine glands, particularly the salivary glands, leading to progressive glandular dysfunction and xerostomia1. Over the years, multiple classification criteria for SjD have consistently designated focal lymphocytic sialadenitis, identified histologically by labial salivary gland biopsy (LSGB), as a key diagnostic criterion2,3,4. This histopathological feature demonstrates higher specificity than subjective clinical manifestations such as xerostomia, particularly in patients with suspected SjD when serological markers (e.g., anti-SSA/Ro) or other clinical features are equivocal or absent. In addition to its established role in diagnostic classification, LSGB provides clinically relevant prognostic information, most notably regarding the risk of lymphoma development, applicable to both seronegative and seropositive patients5. However, LSGB remains technically challenging, particularly for junior rheumatologists, due to factors such as the inherent slipperiness of the labial mucosa. Conventional manual lip retraction often requires either an additional operator or patient cooperation, which considerably complicates the procedure.
To ensure mechanical stabilization of the everted lip and achieve controlled, localized tissue compression, a dedicated clamping device was utilized. This lip fixation device comprises a pressure ring and a backing plate, both rigidly stabilized by a precision screw mechanism, enabling uniform and precisely adjustable compression while effectively immobilizing the everted lip during labial salivary gland biopsy. Compared with conventional LSGB methods, the proposed device-assisted approach reduces procedure time, provides consistent compression with minimal bleeding, reduces inter-operator variability, and offers a more accessible and reproducible technique-rendering it especially suitable for junior clinicians, solo practitioners, and resource-constrained settings where assistant support is limited or unavailable.
Access restricted. Please log in or start a trial to view this content.
This study was approved by the Medical Ethics Committee of Sun Yat-sen Memorial Hospital (approval no. SYSEC-KY-KS-2018-012). All procedures were performed in accordance with the principles of the Declaration of Helsinki.
1. Preparation (Figure 1)
2. Patient positioning
3. Pre-operative assessment
4. Surgical field setup and anesthesia
5. Stabilization
6. Incision and dissection
7. Closure and hemostasis
Access restricted. Please log in or start a trial to view this content.
A prospective study was conducted among 470 patients with suspected SjD who underwent LSGB, approved by the Medical Ethics Committee of Sun Yat-sen Memorial Hospital. The cohort comprised 443 women (94%) with a mean age of 45.8 ± 14.5 years, who underwent LSGB utilizing the lip fixation device from October 2020 to June 2025. Among the cohort, 279 patients (59.3%) exhibited a labial focus score (FS) of ≥1, with all biopsy sample areas measuring greater than 8 mm², demonstrating the reliability of the protocol in obtaining...
Access restricted. Please log in or start a trial to view this content.
The success of our lip fixation device-assisted LSGB technique depends on several critical procedural steps. First and foremost, precise device positioning is critical. Orient the major axis of the oval pressure ring perpendicular to the vermilion border, and align the vertical incision (5-7 mm in length) parallel to the major axis of the pressure plate to ensure optimal surgical exposure and effective compression-induced hemostasis. Conversely, aligning the incision along the minor axis of the pressure plate compromises...
Access restricted. Please log in or start a trial to view this content.
All authors declare that there are no conflicts of interest pertaining to this study. Specifically, Jia-Zhe Li, Jun-Mei Feng, Hong Lan, Lie Dai, Zhi-Ming Ouyang, and Ying-Qian Mo affirm that they have no financial or personal relationships with any organizations or entities that could unduly influence or bias the research presented in this manuscript. The lip fixation device described in this study was developed exclusively for research purposes and is devoid of any commercial affiliations or financial incentives for the authors. None of the authors holds patents, stocks, or receives royalties related to the device; furthermore, there are no competing interests concerning its clinical application. All authors contributed intellectually to this work without any external pressures or influences that could constitute a conflict of interest.
The study was conducted with complete transparency and adherence to ethical guidelines, supported by non-commercial funding from the National Natural Science Foundation of China (Grant No. 82371808) and the Natural Science Foundation of Guangdong Province (Grant No. 2023A1515011922), and Sun Yat-sen Pilot Scientific Research Fund (Grant No. YXQH202604). These funding bodies had no involvement in study design, data interpretation, or manuscript preparation.
Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| Blade | Shanghai jinghuan medicial | 20212020337 | |
| Gauze | Winner medical Co., Ltd | 20140001 | |
| Lip Fixation Device | Cnstrong | 9CM-large | Material Specifications 18Cr" (18% Chromium stainless steel) Disinfection method: High-pressure steam sterilization |
| Needle holder | Geister Medical Co., Ltd. | 20121010135 | |
| Scalpel handle | Shanghai Medical Devices (Group) Co., Ltd. Surgical Instrument Factory | 20121010945 | |
| Scandonest | Septodont | 86978859000048 | containing 2% (w/v) mepivacaine hydrochloride and epinephrine at a concentration of 1:100,000 |
| Small dissecting scissors | Alcon Laboratories, Inc. | 20172041227 | |
| Sterile cotton balls | Qingdao Aibaze Medical Co., Ltd. | 20150153 | |
| Sterile fenestrated surgical drape | Nanchang Tongda Medical Devices Co., Ltd. | 20202140426 | |
| Suture | Hangzhou huawei medical supples Co.,LTD | 20142020178 | |
| Syringe (1 mL) | Shandong Weigao Group Medical Polymer Products Co., Ltd. | 20163141593 | |
| Tissue forceps | Shanghai Medical Devices (Group) Co., Ltd. Surgical Instrument Factory | 20051010331 | |
| Type III Povidone-Iodine Solution | Winner medical Co., Ltd | 20150209 | 0.45%–0.55% iodine, 0.09%–0.11% chlorhexidine gluconate; alcohol-free |
Access restricted. Please log in or start a trial to view this content.